News & Analysis on the Clinical Development and Manufacture of Large Molecule Drugs
Contract development and manufacturing organization, Catalent, has invested in the capabilities at its clinical supply services facility in Philadelphia, in the US, to further support biotech firms developing cell and gene therapies.
US biopharma firm, TG Therapeutics, has announced an expanded contract manufacturing deal with Samsung Biologics to support the production of its investigational anti-CD20 monoclonal antibody, ublituximab.
Medicago has started a rolling submission with Health Canada for its plant-derived adjuvanted COVID-19 vaccine candidate: championing a unique and versatile platform that can also be scaled up easily.
Sanofi will help manufacture up to 200 million doses of Moderna’s COVID-19 vaccine: marking the third COVID-19 vaccine it is involved in producing.